AAA formation is initiated by an influx of immune cells that secrete inflammatory cytokines (TNF-α, IL-1β, IL-6, MCP-1) and activate metalloproteinases, resulting in smooth muscle apoptosis, extracellular matrix degradation, and elastin fragmentation [44, 45]. The gene discussed is CCL2; the disease is triple-A syndrome.